Vera Reinstadler

458 total citations
15 papers, 360 citations indexed

About

Vera Reinstadler is a scholar working on Molecular Biology, Spectroscopy and Toxicology. According to data from OpenAlex, Vera Reinstadler has authored 15 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Spectroscopy and 3 papers in Toxicology. Recurrent topics in Vera Reinstadler's work include Metabolomics and Mass Spectrometry Studies (4 papers), Analytical Chemistry and Chromatography (3 papers) and Forensic Toxicology and Drug Analysis (3 papers). Vera Reinstadler is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (4 papers), Analytical Chemistry and Chromatography (3 papers) and Forensic Toxicology and Drug Analysis (3 papers). Vera Reinstadler collaborates with scholars based in Austria, Germany and United Kingdom. Vera Reinstadler's co-authors include Herbert Oberacher, Marco Kreidl, Susanne Huber, Muthanna Abdulkarim, Felix Prüfert, Max Jelkmann, Andreas Bernkop‐Schnürch, Sonja Bonengel, Mark Gumbleton and Michael Böettcher and has published in prestigious journals such as The Science of The Total Environment, Journal of Controlled Release and Diabetologia.

In The Last Decade

Vera Reinstadler

15 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vera Reinstadler Austria 9 114 64 59 55 52 15 360
Adam J. Gushgari United States 7 49 0.4× 73 1.1× 5 0.1× 112 2.0× 73 1.4× 8 320
Daniela Orsi Italy 11 54 0.5× 41 0.6× 8 0.1× 65 1.2× 21 0.4× 21 428
Kay Roberts United Kingdom 11 57 0.5× 26 0.4× 18 0.3× 141 2.6× 21 0.4× 27 474
Ivona Krizman-Matasic Croatia 9 33 0.3× 325 5.1× 5 0.1× 93 1.7× 50 1.0× 12 459
Lee T. Grady United States 11 50 0.4× 35 0.5× 55 0.9× 74 1.3× 26 0.5× 36 459
Nathalie Cartiser France 12 89 0.8× 141 2.2× 6 0.1× 107 1.9× 7 0.1× 25 609
Ji Young Ryu South Korea 12 126 1.1× 54 0.8× 4 0.1× 121 2.2× 11 0.2× 32 604
Qiuxia Yang China 9 51 0.4× 26 0.4× 11 0.2× 12 0.2× 34 0.7× 27 365
Manuela Peschka Germany 9 32 0.3× 180 2.8× 8 0.1× 90 1.6× 31 0.6× 12 351
Pramila Singh United States 13 78 0.7× 125 2.0× 7 0.1× 334 6.1× 52 1.0× 39 607

Countries citing papers authored by Vera Reinstadler

Since Specialization
Citations

This map shows the geographic impact of Vera Reinstadler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vera Reinstadler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vera Reinstadler more than expected).

Fields of papers citing papers by Vera Reinstadler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vera Reinstadler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vera Reinstadler. The network helps show where Vera Reinstadler may publish in the future.

Co-authorship network of co-authors of Vera Reinstadler

This figure shows the co-authorship network connecting the top 25 collaborators of Vera Reinstadler. A scholar is included among the top collaborators of Vera Reinstadler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vera Reinstadler. Vera Reinstadler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Reinstadler, Vera, Susanne Eder, Hiddo J.L. Heerspink, et al.. (2024). Non-adherence to cardiometabolic medication as assessed by LC-MS/MS in urine and its association with kidney and cardiovascular outcomes in type 2 diabetes mellitus. Diabetologia. 67(7). 1283–1294. 3 indexed citations
2.
Brigo, Natascha, Christa Pfeifhofer‐Obermair, Markus Seifert, et al.. (2023). Timing of Interleukin-4 Stimulation of Macrophages Determines Their Anti-Microbial Activity during Infection with Salmonella enterica Serovar Typhimurium. Cells. 12(8). 1164–1164. 2 indexed citations
3.
Reinstadler, Vera, et al.. (2023). A rapid and convenient sample preparation method for the analysis of cannabinoids in oral fluid samples. Biomedical Chromatography. 37(8). e5651–e5651. 4 indexed citations
4.
Huber, Carolin, Martin Krauß, Vera Reinstadler, et al.. (2022). In silico deconjugation of glucuronide conjugates enhances tandem mass spectra library annotation of human samples. Analytical and Bioanalytical Chemistry. 414(8). 2629–2640. 10 indexed citations
5.
Reinstadler, Vera, et al.. (2022). Human tissue distribution of caspofungin. International Journal of Antimicrobial Agents. 59(4). 106553–106553. 4 indexed citations
6.
Reinstadler, Vera, R A Gutmann, Florian Pitterl, Klaus Winkler, & Herbert Oberacher. (2022). Gas Chromatography—High-Temperature Proton-Transfer Reaction Mass Spectrometry as a Novel Tool for Forensic Drug Testing. Separations. 9(11). 328–328. 1 indexed citations
7.
Caballero‐Casero, Noelia, Lidia Belova, Philippe Vervliet, et al.. (2021). Towards harmonised criteria in quality assurance and quality control of suspect and non-target LC-HRMS analytical workflows for screening of emerging contaminants in human biomonitoring. TrAC Trends in Analytical Chemistry. 136. 116201–116201. 47 indexed citations
8.
Oberacher, Herbert, Vera Reinstadler, Christina Hartmann, et al.. (2021). A preliminary study on the detection of potential contaminants in the European brown hare (Lepus europaeus) by suspect and microplastics screening. Environmental Advances. 4. 100045–100045. 20 indexed citations
9.
Reinstadler, Vera, et al.. (2021). Analysis of cannabis seizures by non-targeted liquid chromatography-tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 205. 114313–114313. 10 indexed citations
10.
Zollner, Andreas, Vera Reinstadler, Simon Reider, et al.. (2021). Tofacitinib-Induced Modulation of Intestinal Adaptive and Innate Immunity and Factors Driving Cellular and Systemic Pharmacokinetics. Cellular and Molecular Gastroenterology and Hepatology. 13(2). 383–404. 19 indexed citations
11.
Reinstadler, Vera, et al.. (2020). Monitoring drug consumption in Innsbruck during coronavirus disease 2019 (COVID-19) lockdown by wastewater analysis. The Science of The Total Environment. 757. 144006–144006. 107 indexed citations
12.
Reinstadler, Vera, et al.. (2019). Cerebrospinal Fluid Drug Concentrations and Clinical Outcome of Patients with Neoplastic Meningitis Treated with Liposomal Cytarabine. European Journal of Drug Metabolism and Pharmacokinetics. 44(6). 845–851. 4 indexed citations
13.
Oberacher, Herbert, Vera Reinstadler, Marco Kreidl, et al.. (2018). Annotating Nontargeted LC-HRMS/MS Data with Two Complementary Tandem Mass Spectral Libraries. Metabolites. 9(1). 3–3. 29 indexed citations
14.
Bonengel, Sonja, Max Jelkmann, Muthanna Abdulkarim, et al.. (2018). Impact of different hydrophobic ion pairs of octreotide on its oral bioavailability in pigs. Journal of Controlled Release. 273. 21–29. 69 indexed citations
15.
Reinstadler, Vera, et al.. (2018). A validated workflow for drug detection in oral fluid by non-targeted liquid chromatography-tandem mass spectrometry. Analytical and Bioanalytical Chemistry. 411(4). 867–876. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026